Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome

ClinicalTrials.gov ID: NCT03226444

Public ClinicalTrials.gov record NCT03226444. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 20, 2026, 7:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Masked, Randomized, Multi-Center Phase 2 Study to Evaluate the Efficacy and Safety of Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome

Study identification

NCT ID
NCT03226444
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
TearSolutions, Inc.
Industry
Enrollment
204 participants

Conditions and interventions

Interventions

  • 0.005% Lacripep Drug
  • 0.01% Lacripep Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2017
Primary completion
Dec 26, 2019
Completion
Dec 26, 2019
Last update posted
Jan 21, 2020

2017 – 2019

United States locations

U.S. sites
35
U.S. states
21
U.S. cities
34
Facility City State ZIP Site status
University of Alabama Eye Center Birmingham Alabama 35294
Doctor My Eyes / Stephen Cohen, OD, PC Scottsdale Arizona 85254
Schwartz Laser Eye Center Scottsdale Arizona 85260
Milton M. Hom, OD FAAO FACAA (Sc) Azusa California 91702
University of California, Berkeley, School of Optometry Berkeley California 94720
Orange County Ophthalmology Garden Grove California 92843
Lugene Eye Institute Glendale California 91204
Martel Eye Medical Group Rancho Cordova California 95670
Wolstan & Goldberg Eye Associates Torrance California 90505
University of Colorado Department of Ophthalmology Aurora Colorado 80045
Corneal Consultants of Colorado Littleton Colorado 80209
Bruce A. Segal, MD PA Private Practice Delray Beach Florida 33484
Bowden Eye & Associates Jacksonville Florida 32256
International Eye Associates, PA Ormond Beach Florida 32174
Perez Eye Center Tampa Florida 33603
Eye Consultants of Atlanta Atlanta Georgia 30339
Chicago Cornea Consultants, Ltd. Hoffman Estates Illinois 60169
Midwest Cornea Associates, LLC Indianapolis Indiana 46290
The Eye Care Institute Louisville Kentucky 40206
Clinical Eye Research of Boston Winchester Massachusetts 01890
Minnesota Eye Consultants, P.A. Bloomington Minnesota 55431
Tauber Eye Center Kansas City Missouri 64111
Ophthalmology Associates St Louis Missouri 63131
Cornea Consultants of Albany Slingerlands New York 12159
Cornerstone Eye Care, PA High Point North Carolina 27262
Bergstrom Eye Research Fargo North Dakota 58103
Abrams Eye Center Cleveland Ohio 44115
Ophthalmic Surgeons & Consultants of Ohio; The Eye Center of Columbus Columbus Ohio 43215
University of Pennsylvania Scheie Eye Institute Philadelphia Pennsylvania 19104
Black Hills Eye Institute Rapid City South Dakota 57701
UTHSC Department of Ophthalmology Memphis Tennessee 38163
The Eye Clinic of Texas, an affiliate of Houston Eye Associates League City Texas 77573
University of Virginia University Eye Center Charlottesville Virginia 22903
Virginia Eye Consultants Norfolk Virginia 23502
Vistar Eye Center Roanoke Virginia 24011

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03226444, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 21, 2020 · Synced Jul 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03226444 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →